Article
Manipulating megakaryocytes to manufacture platelets ex vivo.
Journal of thrombosis and haemostasis : JTH - 1 Jun 2015
Karagiannis P, Eto K
Abstract excerpt
Historically, platelet transfusion has proven a reliable way to treat patients suffering from thrombocytopenia or similar ailments. An undersupply of donors, however, has demanded alternative platelet sources. Scientists have therefore sought to recapitulate the biological events that convert hematopoietic stem cells into platelets in the laboratory. Such platelets have shown good function and potential for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
